Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 39, 2007 - Issue 1
Submit an article Journal homepage
172
Views
5
CrossRef citations to date
0
Altmetric
LETTER TO THE EDITOR

Acute renal failure caused by intravenous acyclovir for disseminated varicella zoster virus infection

Ai Mihara From the Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Takehiko Mori From the Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, JapanCorrespondence[email protected]
,
Tomonori Nakazato From the Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
,
Yasuo Ikeda From the Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
&
Shinichiro Okamoto From the Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan
Pages 94-95 | Received 03 Jun 2006, Published online: 08 Jul 2009

References

  • Brigden D, Rosling AE, Woods N. Renal function after acyclovir intravenous injection. Am J Med 1982; 73(Suppl 1A)182–5
  • Bean B, Braun C, Balfour HH. Acyclovir therapy for acute herpes zoster. Lancet 1982; 2: 118–21
  • Bean B, Aeppli D. Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis 1985; 151: 362–5
  • Sawyers MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure. Am J Med 1988; 84: 1067–71
  • Bianchetti MG, Roduit C, Oetliker OH. Acyclovir-induced renal failure: course and risk factors. Pediatr Nephrol 1991; 5: 238–9
  • Krieble BF, Rudy DW, Glick MR, Clayman MD. Acyclovir neurotoxicity and nephrotoxicity: the role for hemodialysis. Am J Med Sci 1993; 305: 36–9
  • Spiegal DM, Lau K. Acute renal failure and coma secondary to acyclovir therapy. JAMA 1986; 255: 1882–3
  • Wagstaff AJ, Faulds D, Goa KL. Acyclovir: a reappraisal of its activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47: 153–205

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.